Device-drug kit manufacture

A device manufacturer sought Chimera’s advice on stability studies to show that the shelf-life of a drug constituent part was not negatively impacted by the kit sterilization process. Chimera developed technical testing protocols to assess the effects of the kit sterilization method on the drug formulation.